Asia Pacific Herald
SEE OTHER BRANDS

The latest news from Asia and the Pacific

Asia Pacific Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.

Press releases published on May 7, 2025

Rio Moving Launches 'Jane' – An AI Phone Assistant Trained on Over 30,000 Customer Calls

Rio Moving Launches 'Jane' – An AI Phone Assistant Trained on Over 30,000 Customer Calls

Rio Moving Launches “Jane” – An AI Phone Assistant Trained on Over 30,000 Customer Calls WY, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Revolutionizing Customer Service, One Call at a Time Rio Moving, a leading name in professional moving …

MontyCloud and Pax8 Partner to Simplify the Cloud for SMB-focused MSPs

MontyCloud and Pax8 Partner to Simplify the Cloud for SMB-focused MSPs

Pax8 MSPs Can Now Access MontyCloud’s No-Code, AI-Driven CloudOps Platform to Operate Efficiently, Optimize Costs, and Monetize Cloud Services at Scale REDMOND, WA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- MontyCloud Inc., a leading no-code …

APMG Proud to be Part of 5CS Joint Venture – A Gamechanger for Business Case Development

APMG Proud to be Part of 5CS Joint Venture – A Gamechanger for Business Case Development

Transforming business case development with a smart, collaborative, online solution built on the proven Five Case Model. LONDON, HIGH WYCOMBE, UNITED KINGDOM, May 7, 2025 /⁨EINPresswire.com⁩/ -- APMG is delighted to announce the launch of 5CS (Five Case …

InnoCSR and Rango Engineering Solutions Sign Distribution Agreement to Accelerate Adoption of Good Bricks in Nepal

InnoCSR and Rango Engineering Solutions Sign Distribution Agreement to Accelerate Adoption of Good Bricks in Nepal

KATHMANDU, NEPAL, May 7, 2025 /⁨EINPresswire.com⁩/ -- InnoCSR has signed a landmark distribution agreement with Rango Engineering Solutions to accelerate the adoption of sustainable construction practices in Nepal’s Bagmati Province (Province 3). As part …

Retail Media IQ Announces Pre-Seed Raise and Launch of Global Ai-Enhanced Retail Media Platform

Retail Media IQ Announces Pre-Seed Raise and Launch of Global Ai-Enhanced Retail Media Platform

Company Raises $200k and Is One of Few Focused Exclusively on the Rapidly Growing Retail Ad Sector, Which Now Accounts for One in Four CPG Ad Dollars LOS ANGELES, CA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- If success is “partly a function of …

From Beans to Belonging: A Fresh Take on the Humans in Digital Spaces

From Beans to Belonging: A Fresh Take on the Humans in Digital Spaces

Dive into a quirky, whimsical digital oasis for misfits, trendsetters and influencers. LOS ANGELES, CA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Bean$ and Things is a captivating memoir that takes readers on a thrilling journey through the wild …

WF Holding Limited Announces Underwriters’ Exercise of Over-Allotment Option

WF Holding Limited Announces Underwriters’ Exercise of Over-Allotment Option

KUALA LUMPUR, May 07, 2025 (GLOBE NEWSWIRE) -- WF Holding Limited (NASDAQ: WFF) (“WF Holding” or “Company”), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, today announced the underwriters of its initial public offering (the …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

Ayushman Infertility Center Makes Booking Appointments Easy Online

Ayushman Infertility Center Makes Booking Appointments Easy Online

DELHI, NEW DELHI, INDIA, May 7, 2025 /⁨EINPresswire.com⁩/ -- Ayushman Infertility Center, a caring clinic in Delhi that helps people have babies, is happy to announce a new, simple way to book appointments online. This new system will make it easier for …

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it received a staff …

WANG & LEE GROUP, Inc. Bid Price Deficiency

WANG & LEE GROUP, Inc. Bid Price Deficiency

HONG KONG, May 07, 2025 (GLOBE NEWSWIRE) -- WANG …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

Brisbane Based Ian Lazar Digital Commence Features On Latest Medical and Dental Devices

Brisbane Based Ian Lazar Digital Commence Features On Latest Medical and Dental Devices

Leading Sydney Lifestyle Magazine Ian Lazar Digital confirmed commencing featured posts focusing the work of Australian medical and Dental supply companies. BRISBANE, QLD, AUSTRALIA, May 7, 2025 /⁨EINPresswire.com⁩/ -- Ian Lazar Digital is an online …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

-  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA -  Lead target and portfolio strategy to be announced mid …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …

Century Aluminum Company Reports First Quarter 2025 Results

Century Aluminum Company Reports First Quarter 2025 Results

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data)   Q1 2025   Q4 2024   Aluminum shipments ( …

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service